A heart, they say, beats to its own rhythm. It's an individual's lifeline, a ticking timepiece choreographed by nature. In 2018, my life took an unexpected turn, and my own rhythm led me to Japan, a captivating place known for its intricate blend of tradition and technology. Armed with my previous experience of working on a project for Parkinson's disease management, I was ready to dive deeper into the pulsating world of AI and healthcare. I was about to tackle the silent and often undetected malady - arrhythmia. This condition, which brings an irregular heartbeat, often foreshadows severe heart disease. Tasked with finding a way to detect such irregularities, I was introduced to a challenge that piqued my intellectual curiosity. I knew I had my work cut out for me, but a part of me was excited to navigate these uncharted waters. Japan was different, an experience that I can only liken to the feeling you get when you open a book you’ve never read before. It's the first line that hooks you, and before you know it, you're engrossed, living the characters' lives. And just like that, I found myself living my new life, absorbed in a culture rich in tradition, and working at the cutting-edge of AI at Fujitsu AI Laboratories. The project felt a bit like a solitary journey, and in this isolation, I found a certain kind of quiet determination. I was working on the deep end of deep learning, navigating through an intricate web of algorithms, pushing the boundaries of what was possible. The task was clear: develop a technology capable of not only identifying arrhythmia but doing so in a way that was beyond the capabilities of Electrocardiography (ECG). Our not-so-secret weapon was Topological Data Analysis (TDA), a robust waveform analysis technology. TDA had the unique capability to create AI models that could detect anomalies in time-series data. Its resilience to data deformations was exactly what we needed for our ambitious endeavor. With TDA, we were able to fine-tune our technology to detect arrhythmia with a high level of accuracy, even in patients previously unseen by the system. In due course, the results of our labor began to bear fruit. We were granted a patent for our technology, a validation that served as a testament to our innovative approach. Moreover, our scholarly paper detailing our work was selected for presentation at the Canadian Conference on Artificial Intelligence in 2020, an honor that I cherish. Later, the paper found a place in the prestigious 'Springer Nature'. By October 2021, the technology that was born out of a solitary journey and persistent exploration was being put to the test in a clinical trial with The University of Tokyo Hospital. It was no longer just lines of code and algorithms; it was being used to possibly save lives, to make a tangible difference. This was not just a breakthrough for us, but it also brought new hope for the early detection of heart diseases. The technology continues to be used in Tokyo clinics, contributing to the fight against the global issue of heart disease. From the heart of Tokyo to the very core of AI in healthcare, my journey has been nothing short of extraordinary. Through it all, I've learned that when you're at the intersection of healthcare and AI, the potential for impact is not just huge, it's heartwarming. Life in Japan, my time at Fujitsu, the work we did - it all syncs together like a harmonious symphony, much like a healthy heartbeat. Reflecting on it, I can confidently say that while this journey came with its own unique challenges, it also came with an equal, if not greater, amount of satisfaction. As the story continues to unfold, I look forward to sharing more chapters with you. The heart of this tale beats on, rhythm by rhythm, line by line, one innovation at a time.
